Quantcast
Channel: Law and Biosciences Blog » Myriad
Browsing all 12 articles
Browse latest View live

Stanford Panel on the Gene Patents Controversy

October 10, 2011 from 4:30 pm – 6:00 pm Stanford Law School, Room 190 Last year, the United States District Court for the Southern District of New York shocked the IP world by declaring Myriad’s BRCA...

View Article



Stay tuned for analysis and commentary on the Supreme Court’s decision in...

In a surprising unanimous decision, the Supreme Court has invalidated a patent for “a diagnostic method to observe changes in a patient’s body to determine the best drug dosage for certain diseases.”...

View Article

The Supreme Court Decides Mayo v. Prometheus, Strikes Down Patents

Earlier today, the Supreme Court released its decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., the latest highly anticipated installment in the Court’s grappling with biotech...

View Article

Quick Note – The Supreme Court Has Gavrilo’d the Myriad Case

Granted, vacated, and remanded in light of . . .  Prometheus. ASSN. FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, ET AL. The petition for a writ of certiorari is granted. The judgment is vacated, and the...

View Article

Prometheus v. Mayo: Subject Matter Eligibility and Composition of Matter

The Court in Prometheus highlights that determining subject matter eligibility under section 101 is now a necessary inquiry of patentability. Some had argued that other requirements of patentability,...

View Article


Federal Circuit Decides AMP v. Myriad (Again)

The Federal Circuit yesterday issued its opinion in AMP v. Myriad.  The Supreme Court had remanded the Myriad case (GVR) in light of its decision in Prometheus v. Mayo.  The Prometheus case held that a...

View Article

AMP v. Myriad: The End of Gene Patents?

There are several notable aspects to the Federal Circuit’s recent AMP v. Myriad redecision. Of particular interest is the court’s scientific claims: that because isolated DNA and cDNA sequences are...

View Article

AMP v. Myriad – Again!

The Court of Appeals for the Federal Circuit just decided the AMP v. Myriad case after the Supreme Court gavrilo’d (granted, vacated, and remanded) it in light of Mayo v. Prometheus. The case went back...

View Article


ACLU Files Cert Petition in Myriad Case

On Monday, the ACLU filed its petition for certiorari to the Supreme Court, challenging Myriad Genetics’ patents concerning the testing of mutations in two genes, BRCA1 and BRCA2, to diagnose several...

View Article


AMP v. Myriad Genetics Oral Argument Recap

Today’s oral arguments in Association for Molecular Pathology v. Myriad Genetics were wide-ranging–and often-times confusing. Almost all of the Justices seemed struggled with basic principles of...

View Article

Myriad Decision Invoked in Appeal of Suit To Invalidate Embryonic Stem Cell...

On June 13, the U.S. Supreme Court struck down patent claims of Myriad Genetics to genomic DNA in the BRCA1 and BRCA2 genes on the ground that those patents claimed mere “products of nature.”  Only...

View Article

The World vs. Myriad(’s Patents’ Validity)

In the latest salvo in Myriad Genetic’s bloody patent disputes with its BRCA-testing competitors, Myriad has sued LabCorp after the company announced it was to begin offering its own BRCA-testing...

View Article
Browsing all 12 articles
Browse latest View live




Latest Images